Complications of Heparin Treatment
The most severe complication, known as type II heparin-induced thrombocytopenia (HIT) has long been difficult to diagnose in the absence of any straightforward laboratory tests. Working hand-in-hand with a hospital clinical research unit, Stago R&D developed a standardised diagnostic kit essential for adjusting anticoagulant therapy in these patients, thereby reducing the risk of complications.
Read more
STA - Procoag-PPL or making microparticles talk
Midway between plasma haemostasis and cellular haemostasis are microparticles, rich in procoagulant phospholipids. An increase in this procoagulant activity is described in many disease processes, including cardiovascular disorders, certain cancers, inflammatory syndromes, infectious diseases and so on.
Read more
Remaining abreast of changes in biology
Listening to and exchanging ideas with actors in the world of medical biology has enabled Stago to develop its expertise in the search for solutions in such a way as to anticipate and integrate these changes.
Read more